Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CLINICA 100 TOP 10: Danaher

This article was originally published in Clinica

Executive Summary

Edging its way into the Top 10 for the first time is Danaher. The company moved up one position to No 10 in our Clinica 100 league table*. It continues to be No 2 in the IVD list, behind Roche. Danaher was involved in one of 2015’s mega-mergers, making its biggest buy ever with a $13.8bn deal for filtration technology specialist Pall. The companies serve not only the life sciences market (Danaher more so than Pall) but also other non-healthcare related industries (Pall more so than Danaher). With the acquisition of Pall, the bulked up Danaher plans to split into two publicly listed companies – the concern that will retain the Danaher name will encompass Danaher’s life sciences, diagnostics and dental segments and the other concern will consists of the water quality and product identification platforms and most of the acquired Pall businesses.

You may also be interested in...

Could Alcon's CyPass Trouble Be Boon For Glaukos – Or Bust For MIGS?

Minimally invasive glaucoma surgery specialist Glaukos saw its stock leap 40% in the wake of a worldwide recall by much bigger rival Alcon of its CyPass microstent.

Roche Dx' EMEA Head To Take Charge After Diggelmann Departs

Roland Diggelmann will end his decade-long career at Roche Diagnostics at the end of September. The business's head of EMEA Michael Heuer will take Diggelmann's place while the search is on for his replacement.

Nose For A Good Tech? Philips Adds Nasal Alar Pulse Oximetry To Monitoring Portfolio

Philips has added a new pulse oximetry platform to its patient monitoring portfolio, with the acquisition of Xhale Assurance.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts